Active Biotech AB (ACTI)

Currency in SEK
5.160
-0.340(-6.18%)
Closed·
ACTI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.1605.380
52 wk Range
3.70018.250
Key Statistics
Prev. Close
5.5
Open
5.23
Day's Range
5.16-5.38
52 wk Range
3.7-18.25
Volume
70.31K
Average Volume (3m)
185.38K
1-Year Change
-69.397%
Book Value / Share
1.79
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACTI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
07/05/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare ACTI to Peers and Sector

Metrics to compare
ACTI
Peers
Sector
Relationship
P/E Ratio
−3.9x−1.6x−0.4x
PEG Ratio
−0.06−0.030.00
Price/Book
2.9x2.1x2.6x
Price / LTM Sales
-16.6x3.0x
Upside (Analyst Target)
384.5%140.9%53.5%
Fair Value Upside
Unlock11.2%9.0%Unlock

Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematological malignancies; Laquinimod, an immunomodulator for the treatment of severe inflammatory eye diseases, such as non-infectious non anterior uveitis; and Naptumomab estafenatox, a tumor targeting immunotherapy to treat patients with solid tumors. The company has collaboration with Abramson Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, Texas and Stictching-Haemato-Oncologie Volwassenen Netherlands, as well as Stanford Medicine and the Global Ophthalmic Research Center. The company was incorporated in 1983 and is headquartered in Lund, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
7.76M29.42%40.02M
Public Companies & Retail Investors
18.61M70.58%96.00M
Total
26.36M100.00%136.02M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
MGA Holding AB12.98%3,421,85017,657
Sjuenda Holding AB7.33%1,933,4009,976

People Also Watch

11.360
VICOR
-0.87%
5.98
CINT
0.00%
1.84
CANTA
-4.18%
19.68
SYNACT
+0.41%
0.44
NICA
-4.34%

FAQ

What Is the Active Biotech (Stockholm: ACTI) Share Price Today?

The Active Biotech stock price today is 5.160 SEK.

What Stock Exchange Does Active Biotech (ACTI) Trade On?

Active Biotech is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for Active Biotech?

The stock symbol (also called a 'ticker') for Active Biotech is "ACTI."

What Is the Current Active Biotech Market Capitalisation?

As of today, Active Biotech (Stockholm: ACTI) market cap is 136.020M SEK.

What Is Active Biotech's (ACTI) Earnings Per Share (TTM)?

The Active Biotech EPS is currently -2.150 (Trailing Twelve Months).

When Is the Next Active Biotech Earnings Date?

Active Biotech's next earnings report will be released on 20/08/2026.

Is ACTI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Active Biotech moving averages and other technical indicators, the daily buy/sell signal for ACTI stock is Strong Sell.

How Many Times Has Active Biotech Stock Split?

Active Biotech has split 11 times. (See the ACTI stock split history page for full effective split date and price information.)

How Many Employees Does Active Biotech Have?

Active Biotech has 5 employees, based on their latest Companies House report.

What is the current trading status of Active Biotech (Stockholm: ACTI)?

As of 19/07/2026, Active Biotech (ACTI) is trading at a share price of 5.160 SEK, with a previous close of 5.500 SEK. The stock has fluctuated within a day range of 5.160 SEK to 5.380 SEK, while its 52-week range spans from 3.700 SEK to 18.250 SEK.

What Is Active Biotech (ACTI) Price Target According to Analysts?

The average 12-month price target for Active Biotech is 25.000 SEK, with a high estimate of 25 SEK and a low estimate of 25 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +384.50% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.